FDA Panel Votes Against Expanding Use of Amgen Drug Xgeva
A federal advisory panel rejected a proposal by Amgen to expand the use of its bone drug Xgeva in men with prostate cancer that has not spread to the bones. (Source: WSJ.com: Health)

Major Study Finds Miscarriage Risk Higher for Nurses...
January 27, 2012 - A recent study published by the American Journal of Obstetrics and Gynecology has found the rate of spontaneous abortion in nurses who handle chemotherapy drugs to be twice that in nurses who did not handle these drugs. Past studies have yielded similar results, but this study, done in partnership with National Institute for Occupational Safety and Health (NIOSH) and the Nurses’ Health Study 2, used a significantly larger sample size of nearly 7,000 nurse pregnancies. The study looked at five potentially hazardous exposures: x-rays, chemotherapy drugs, sterilizing agents, anesthetic gases and antiviral drugs. (Source: NurseZone.com Nursing News)